SCHEMBL6708065

SCHEMBL6708065

O=C(CCC(=O)Oc1cccc2ccccc12)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPT P10636 2/20 0.49
CASP1 P29466 1/20 0.49
MRGPRX4 Q96LA9 1/20 0.49
ALDH1A1 P00352 6/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
MAPK1 P28482 3/20 0.49
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
GAA P10253 2/20 0.47
PGR P06401 1/20 0.47
PTGS1 P23219 1/20 0.47
MEN1 O00255 1/20 0.46
RAB9A P51151 1/20 0.46
PIN1 Q13526 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11370297 0.86 ALDH1A1 (0.59) CYP1A2CYP2C19HSD17B10KMT2AALDH1A1
SCHEMBL7277418 0.84 MRGPRX4 (0.54) KMT2AMAPTCASP1MRGPRX4ALDH1A1
SCHEMBL28289914 0.84 KMT2A (0.54) HSD17B10KMT2AMRGPRX4ALDH1A1L3MBTL1
SCHEMBL10595010 0.84 HSD17B10 (0.54) HSD17B10KMT2AMAPTCASP1MRGPRX4
SCHEMBL11370296 0.83 ALDH1A1 (0.58) CYP1A2HSD17B10KMT2AMAPTMRGPRX4
SCHEMBL27493266 0.82 ALDH1A1 (0.53) HSD17B10KMT2AALDH1A1L3MBTL1MAPK1
SCHEMBL6708188 0.81 MRGPRX4 (0.45) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL3051266 0.81 ALDH1A1 (0.65) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
Adipic Acid SCHEMBL28144622 0.81 ALDH1A1 (0.55) CYP1A2CYP2C19HSD17B10KMT2AMAPT
SCHEMBL3290432 0.80 HSD17B10 (0.56) HSD17B10KMT2AMRGPRX4ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-0831826-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE F. HOFFMANN-LA ROCHE AG (CH) 1998-04-01 EP disclosed
WO-1996039142-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE F. HOFFMANN-LA ROCHE AG (CH) 1996-12-12 WO disclosed